Security key
034569103
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)
CUSIP: 034569103
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 7,031,883
- Total 13F value
- $16,498,373
- Share change
- +195,753
- SEC-reported price per share
- $2.35
- Number of holders
- 11
- Value change
- +$460,020
- Number of buys
- 4
- Number of sells
- 2
- Shares outstanding
- 41,587,315
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
11
Top holders
10
ANEB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Anebulo Pharmaceuticals, Inc. SEC filings
Anebulo Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 034569103
Recent filing periods:
Ownership snapshot
Top reported holders of ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
22NW, LP
Disclosed value leader
22NW, LP
Comparable rows
9/11
Latest evidence
31 Mar 2023
13F
3/4/5
Lead comparable stake: 12%
2 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
22NW, LP leads the comparable SEC ownership view at 12%.
9 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens 22NW, LP's linked filing trail.
Comparable ownership
Top 5
22NW, LP
12%
LVW Advisors, LLC
1.6%
Nantahala Capital Management, LLC
1.2%
MANGROVE PARTNERS IM, LLC
0.96%
Ikarian Capital, LLC
0.38%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| 22NW, LP |
13F
Company
|
12%
|
$14,692,241
5,066,290 shares
|
— | 31 Mar 2023 |
| LVW Advisors, LLC |
13F
Company
|
1.6%
|
$1,952,660
673,331 shares
|
— | 31 Mar 2023 |
| Nantahala Capital Management, LLC |
13F
Company
|
1.2%
|
$1,482,112
511,073 shares
|
— | 31 Mar 2023 |
| MANGROVE PARTNERS IM, LLC |
13F
Company
|
0.96%
|
$1,157,735
399,219 shares
|
— | 31 Mar 2023 |
| Ikarian Capital, LLC |
13F
Company
|
0.38%
|
$462,360
156,203 shares
|
— | 31 Mar 2023 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
0.04%
|
$50,225
17,319 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
7,031,883
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
9
Q2 2023 holders
11
Holder diff
2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend